Next report date
Report period
Q1 2024
EPS estimate
−0.35SEK
Revenue estimate
—
−215.81 MSEK
25.03 M
Om SYNACT PHARMA AB
Sektor
Bransch
VD
Jeppe Øvli Øvlesen
Webbplats
Huvudkvarter
Lund
Employees (FY)
5
Grundat
2016
ISIN
SE0008241491
FIGI
BBG00CZP0DV6
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
